Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

Clinical trial NCT00995293 · COMPLETED

Trial details

NCT number: NCT00995293
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2009-08-27
Primary completion: 2018-01-26
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.